Equity
€526,678 ▼ 1.9%
CHAVICO paid out €58,897 in dividends. That is 121% of the 2025 profit.
CHAVICO
Lifetime
20 annual accounts with figures on one time axispeak €284,068 (2022)
€113,205▼ 47.2%
peak €166,632 (2022)
€48,750▼ 56.2%
peak €536,825 (2024)
€526,678▼ 1.9%
€211,456▼ 25.4%
Board1 name since 2006
1 director
Documentsfilings and deeds
04-07-202627 days before the deadline
2025micro format
Gross margin from €214,342 to €113,205Result from €111,237 to €48,750Dividend €58,897Debts from €283,463 to €211,456Cash from €71,238 to €44,617
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 20,135 companies had the same profile as CHAVICO has now. Each dot stands for 51 companies, two years later.
95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,135 companies, not a prediction for CHAVICO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0878629859
Purpose change · Amendment of the articles · Legal-form change · Resignations & appointments
“En assurant la gestion d'une société professionnelle de biologie,en ce compris l'acquisition,la location et…” (deed in French) · Legal-form conversion: to private limited company · Director in office: (statutory director) · Gazette deed
Capital decrease of €55,800 to €18,600
Capital from €74,400 to €18,600 · holds all the shares · General meeting of 18-12-2017 · Gazette deed
First establishment
Chaussée d'Andenne 51, Huy
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| CHAVICO Huy | €738,134 | €113,205 | 71.4% | - |
| SOCIETE MEDICALE Catherine LEMAIRE Liège | €876,450 | €141,170 | 87.3% | - |
| IMMOJUMED Charleroi | €786,954 | €94,986 | 17.4% | - |
| MEDISAB Onhaye | €761,229 | €129,043 | 97.5% | - |
| MANUCARE Anhée | €897,335 | €122,982 | 72.1% | - |
| CABINET DU DR ISABELLE CAPRON Schaerbeek | €606,534 | €104,731 | 73.9% | - |
| DOKTER LUC DE PELECIJN Tervuren | €754,639 | €112,937 | 97.3% | - |
These companies have the same main activity as CHAVICO: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €607,000 and €897,000, founded between 2000 and 2009.
Official details
Source: KBO- Status
- Active since 12-01-2006Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910and 2 others
- Establishment unit
- 2.273.762.7464500 Huy, since 16-01-2006
- Financial year end
- 31 December
- Peppol
- Reachable since 18-06-2025
Annual accounts 2025
- ≈ €230,000estimated
- €738,134▼ 10.0%
- Filing
- Filed on 04-07-2026, 27 days before the end of the filing period
Insights on CHAVICO
CHAVICO files the micro format. That format states no turnover. The gross margin fell from €174,522 in 2006 to €113,205 in 2025.
The balance sheet grew most from 2022 to 2024 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CHAVICO
- What is the company number of CHAVICO?
- The company number of CHAVICO is 0878.629.859. The VAT number is the same number with BE in front: BE 0878.629.859.
- Where is CHAVICO based?
- The registered office is at Chaussée d'Andenne 51, 4500 Huy.Company details
- What does CHAVICO do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of CHAVICO?
- CHAVICO is a private limited company (BV).
- When was CHAVICO founded?
- CHAVICO was founded on 12-01-2006.
- Is CHAVICO still active?
- Yes, CHAVICO is an active enterprise in the KBO register.
- What is the turnover of CHAVICO?
- The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €113,205 and 85 comparable companies (NACE 86). It probably lies between €170,000 and €280,000.Financials
- Is CHAVICO profitable?
- In financial year 2025, CHAVICO made a profit of €48,750.
- Where can I find the annual accounts of CHAVICO?
- CHAVICO filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CHAVICO due?
- CHAVICO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.